Developmental programming: Differential effects of prenatal testosterone excess on insulin target tissues

Endocrinology

Volumn 151, Issue 11, 2010, Pages 5165-5173

  Nada, Shadia E ^a   Thompson, Robert C ^b,c   Padmanabhan, Vasantha ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; HORMONE SENSITIVE LIPASE; INITIATION FACTOR 4E; INSULIN RECEPTOR SUBSTRATE 2; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN INSENSITIVE COMPANION OF MAMMALIAN TARGET OF RAPAMYCIN; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG; ANDROGEN; CHOLESTEROL ESTERASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TESTOSTERONE;

ADIPOSE TISSUE; ARTICLE; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GESTATIONAL AGE; INSULIN RESISTANCE; OVARY POLYCYSTIC DISEASE; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKELETAL MUSCLE; ANIMAL; DRUG EFFECT; FEMALE; LIVER; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHEEP; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; ANDROGENS; ANIMALS; FEMALE; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MUSCLE, SKELETAL; PPAR GAMMA; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, INSULIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHEEP; SIGNAL TRANSDUCTION; STEROL ESTERASE; TESTOSTERONE;

EID: 78049490908     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0666     Document Type: Article

References (64)

1. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
2. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO 2004 The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 89:2745-2749
3. Legro RS, Kunselman AR, Dodson WC, Dunaif A 1999 Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165-169
4. Corbould A, Kim YB, Youngren JF, Pender C, Kahn BB, Lee A, Dunaif A 2005 Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. Am J Physiol Endocrinol Metab 288:E1047-E1054
5. Book CB, Dunaif A 1999 Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 84:3110-3116 (Pubitemid 30646930)
6. Corbould A, Dunaif A 2007 The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome. Metabolism 56:716-722
7. Taylor SI, Kadowaki T, Kadowaki H, Accili D, Cama A, McKeon C 1990 Mutations in insulin receptor gene in insulin-resistant patients. Diabetes Care 13:257-279
8. Muller-Wieland D, Taub R, Tewari DS, Kriauciunas KM, Sethu S, Reddy K, Kahn CR 1989 Insulin-receptor gene and its expression in patients with insulin resistance. Diabetes 38:31-38
9. Imano E, Kadowaki H, Kadowaki T, Iwama N, Watarai T, Kawamori R, Kamada T, Taylor SI 1991 Two patients with insulin resistance due to decreased levels of insulin-receptor mRNA. Diabetes 40:548-557
10. De Fea K, Roth RA 1997 Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J Biol Chem 272:31400-31406 (Pubitemid 28013276)
11. Gual P, Grémeaux T, Gonzalez T, Le Marchand-Brustel Y, Tanti JF 2003 MAP kinases and mTOR mediated insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632. Diabetologia 46:1532-1542
12. Tanti JF, Grémeaux T, van Obberghen E, Le Marchand-Brustel Y 1994 Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem 269:605-6057
13. Corbould A, Zhao H, Mirzoeva S, Aird F, Dunaif A 2006 Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes 55:751-759
14. Abbott DH, Dumesic DA, Levine JE, Dunaif A, Padmanabhan V 2006 Animal models and fetal programming of PCOS. In: Azziz R, Nestler JE, Dewailly D, eds. Contemporary endocrinology. Androgen excess disorders inwomen:polycystic ovary syndrome and other disorders. 2nd ed. Totowa, NJ: Humana Press; 259-272
15. Padmanabhan V, Manikkam, Recabarren S, Foster DL 2006 Prenatal Testosterone Programs Reproductive and Metabolic Dysfunction in the Female. Mol Cell Endocrinology 246:165-174
16. Padmanabhan V, Veiga-Lopez, Abbott DH, Dumesic DA 2007 Developmental programming of ovarian disruption. In: Gonzalez-Bulnes A, ed. Novel concepts in ovarian endocrinology. Kerala, India: Research Signpost; 329-352
17. Padmanabhan V, Sarma HN, Savabieasfahani M, Steckler TL, Veiga-Lopez A 2010 Developmental reprogramming of reproductive and metabolic dysfunction in sheep: native steroids vs. environmental steroid receptor modulators. Int J Androl 33:394-404
18. Manikkam M, Crespi EJ, Doop DD, Herkimer C, Lee JS, Yu S, Brown MB, Foster DL, Padmanabhan V 2004 Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 145:790-798
19. Veiga-Lopez A, Steckler TL, Abbott DH, Welch K, MohanKumar PS, Phillips DJ, Refsal K, Padmanabhan V 25 August 2010 Developmental programming: impact of prenatal testosterone excess on maternal and fetal steroid milieu. Biol Reprod 10.1095/biolreprod.110.086686
20. Manikkam M, Thompson RC, Herkimer C, Welch KB, Flak J, Karsch FJ, Padmanabhan V 2008 Developmental programming: impact of prenatal testosterone excess on pre- and postnatal gonadotropin regulation in sheep. Biol Reprod 78:648-660
21. -ΔΔCT method. Methods 25:402-408
22. Padmanabhan V, Veiga-Lopez A, Abbott DH, Recabarren SE, Herkimer C 2010 Developmental programming: Impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology 151:595-605
23. Cherrington AD 1999 Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes 48:1198-1214
24. Nordlie RC, Foster JD, Lange AJ 1999 Regulation of glucose production by the liver. Annu Rev Nutr 19:379-406
25. McGrattan PD, Wylie AR, Bjourson AJ 1998 A partial cDNA sequence of the ovine insulin receptor gene: evidence for alternative splicing of an exon 11 region and for tissue-specific regulation of receptor isoform expression in sheep muscle, adipose tissue and liver. J Endocrinol 159:381-387
26. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR 2000 Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97
27. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF 1998 Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904
28. Previs SF, Withers DJ, Ren JM, White MF, Shulman GI 2000 Contrasting effects of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem 275:38990-38994
29. Roduit R, Masiello P, Wang SP, Li H, Mitchell GA, Prentki M 2001 A role for hormone-sensitive lipase in glucose-stimulated insulin secretion: a study in hormone-sensitive lipase-deficient mice. Diabetes 50:197-1975
30. Whiteman EL, Cho H, Birnbaum MJ 2002 Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 13:444-451
31. Li X, Monks B, Ge Q, Birnbaum MJ 2007 Akt/PKB regulates hepatic metabolism by directly inhibiting PGC-1α transcription coactivator. Nature 447:1012-1016
32. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw 3rd EB, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ 2001 Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ). Science 292:1728-1731
33. Fingar DC, Blenis J 2004 Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151-3171
34. Fingar DC, Salama S, Tsou C, Harlow E, Blenis J 2002 Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev 16:1472-1487
35. Wullschleger S, Loewith R, Hall MN 2006 TOR signaling in growth and metabolism. Cell 124:471-484
36. Barthel A, Schmoll D 2003 Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol Endocrinol Metab 285:E685-692
37. Suh YH, Kim Y, Bang JH, Choi KS, Lee JW, Kim WH, Oh TJ, An S, Jung MH 2005 Analysis of gene expression profiles in insulin-sensitive tissues from pre-diabetic and diabetic Zucker diabetic fatty rats. J Mol Endocrinol 34:299-315
38. Deng T, Shan S, Li PP, Shen ZF, Lu XP, Cheng J, Ning ZQ 2006 Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1. Endocrinology 147:875-884
39. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H, Tempst P, Sabatini DM 2004 Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 14:1296-1302
40. Postic C, Leturque A, Printz RL, Maulard P, Loizeau M, Granner DK. Girard J 1994 Development and regulation of glucose transporter and hexokinase expression in rat. Am J Physiol Endocrinol Metab 266:E548-E55
41. Nishimoto H, Matsutani R, Yamamoto S, Takahashi T, Hayashi KG, Miyamoto A, Hamano S, Tetsuka M 2006 Gene expression of glucose transporter (GLUT) 1, 3 and 4 in bovine follicle and corpus luteum. J Endocrinol 188:111-119
42. Aschenbach JR, Steglich K, Gäbel G, Honscha KU 2009 Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs. J Physiol Biochem 65:251-266
43. Blanco CL, Liang H, Joya-Galeana J, DeFronzo RA, McCurnin D, Musi N 2010 The ontogeny of insulin signaling in the preterm baboon model. Endocrinology 151:1990-1997
44. Petersen KF, Shulman GI 2002 Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 90:11G-18G
45. Savkur RS, Philips AV, Cooper TA 2001 Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29:40-47
46. Kellerer M, Lammers R, Ermel B, Tippmer S, Vogt B, Obermaier-Kusser B, Ullrich A, Häring HU 1992 Distinct alpha-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities. Biochemistry 31:4588-4596
47. Kosaki A, Pillay TS, Xu L, Webster NJ 1995 The B isoform of the insulin receptor signals more efficiently than the A isoform in HepG2 cells. J Biol Chem 270:20816-20823
48. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R 2009 Insulin receptor isoformsandinsulin receptor/insulin-likegrowthfactor receptor hybrids in physiology and disease. Endocr Rev 30:586-623
49. Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR 2000 Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes 49:263-271 (Pubitemid 30071005)
50. Pearce NJ, Arch JR, Clapham JC, Coghlan MP, Corcoran SL, Lister CA, Llano A, Moore GB, Murphy GJ, Smith SA, Taylor CM, Yates JW, Morrison AD, Harper AJ, Roxbee-Cox L, Abuin A, Wargent E, Holder JC 2004 Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3 on a muscle-specific promoter. Metabolism 53:1322-1330
51. Demissie M, Lazic M, Foecking EM, Aird F, Dunaif A, Levine JE 2008 Transient prenatal androgen exposure produces metabolic syndrome in adult female rats. Am J Physiol Endocrinol Metab 295:E262-E268
52. Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E 2001 Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 281:E392-E399
53. Glintborg D, Højlund K, Andersen NR, Hansen BF, Beck-Nielsen H, Wojtaszewski JF 2008 Impaired insulin activation and dephosphorylation of glycogen synthase in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. J Clin Endocrinol Metab 93:3618-3626
54. Højlund K, Glintborg D, Andersen NR, Birk JB, Treebak JT, Frøsig C, Beck-Nielsen H, Wojtaszewski JF 2008 Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. Diabetes 57:357-366
55. Yu YH, Ginsberg HN 2005 Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 96:1042-1052
56. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556
57. Bays H, Mandarino L, DeFronzo RA 2004 Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab 89:463-478
58. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM 2005 Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex. Science 307:1098-1101
59. Cho HJ, Park J, Lee HW, Lee YS, Kim JB 2004 Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem Biophys Res Commun 321:942-948
60. Argmann CA, Cock TA, Auwerx J 2005 Peroxisome proliferator-activated receptor γ: the more the merrier? Eur J Clin Invest 35:82-92; discussion 80
61. Picard F, Auwerx J 2002 PPARγ and glucose homeostasis. Annu Rev Nutr 22:167-197
62. Cortón M, Botella-Carretero JI, Benguría A, Villuendas G, Zaballos A, San Millán JL, Escobar-Morreale HF, Peral B 2007 Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab 92:328-337
63. Seow KM, Juan CC, Hsu YP, Hwang JL, Huang LW, Ho LT 2007 Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery. Hum Reprod 22:1003-1110
64. Seow KM, Tsai YL, Hwang JL, Hsu WY, Ho LT, Juan CC 2009 Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome. Hum Reprod 24:1982-1988